Logo image of IDN

INTELLICHECK INC (IDN) Stock Fundamental Analysis

NASDAQ:IDN - Nasdaq - US45817G2012 - Common Stock - Currency: USD

5.37  +0.2 (+3.87%)

Fundamental Rating

4

Taking everything into account, IDN scores 4 out of 10 in our fundamental rating. IDN was compared to 282 industry peers in the Software industry. The financial health of IDN is average, but there are quite some concerns on its profitability. IDN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year IDN has reported negative net income.
In the past year IDN has reported a negative cash flow from operations.
In the past 5 years IDN always reported negative net income.
In the past 5 years IDN reported 4 times negative operating cash flow.
IDN Yearly Net Income VS EBIT VS OCF VS FCFIDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of IDN (-3.23%) is comparable to the rest of the industry.
IDN's Return On Equity of -4.51% is in line compared to the rest of the industry. IDN outperforms 58.87% of its industry peers.
Industry RankSector Rank
ROA -3.23%
ROE -4.51%
ROIC N/A
ROA(3y)-9.95%
ROA(5y)-13.83%
ROE(3y)-12.48%
ROE(5y)-17.36%
ROIC(3y)N/A
ROIC(5y)N/A
IDN Yearly ROA, ROE, ROICIDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 90.61%, IDN belongs to the top of the industry, outperforming 98.58% of the companies in the same industry.
IDN's Gross Margin has been stable in the last couple of years.
IDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y0.85%
IDN Yearly Profit, Operating, Gross MarginsIDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

IDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IDN has more shares outstanding
IDN has more shares outstanding than it did 5 years ago.
IDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IDN Yearly Shares OutstandingIDN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
IDN Yearly Total Debt VS Total AssetsIDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

IDN has an Altman-Z score of 2.52. This is not the best score and indicates that IDN is in the grey zone with still only limited risk for bankruptcy at the moment.
IDN has a Altman-Z score (2.52) which is in line with its industry peers.
IDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACCN/A
WACC10.97%
IDN Yearly LT Debt VS Equity VS FCFIDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

IDN has a Current Ratio of 1.95. This is a normal value and indicates that IDN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.95, IDN is in the better half of the industry, outperforming 60.64% of the companies in the same industry.
IDN has a Quick Ratio of 1.95. This is a normal value and indicates that IDN is financially healthy and should not expect problems in meeting its short term obligations.
IDN's Quick ratio of 1.95 is fine compared to the rest of the industry. IDN outperforms 60.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95
IDN Yearly Current Assets VS Current LiabilitesIDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

IDN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, IDN shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
IDN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.16% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y6.86%
Revenue growth 5Y21.16%
Sales Q2Q%4.57%

3.2 Future

Based on estimates for the next years, IDN will show a very strong growth in Earnings Per Share. The EPS will grow by 73.49% on average per year.
The Revenue is expected to grow by 13.17% on average over the next years. This is quite good.
EPS Next Y66.33%
EPS Next 2Y73.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.28%
Revenue Next 2Y13.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IDN Yearly Revenue VS EstimatesIDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
IDN Yearly EPS VS EstimatesIDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 106.34, the valuation of IDN can be described as expensive.
61.35% of the companies in the same industry are cheaper than IDN, based on the Price/Forward Earnings ratio.
IDN is valuated expensively when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 106.34
IDN Price Earnings VS Forward Price EarningsIDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDN Per share dataIDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

IDN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as IDN's earnings are expected to grow with 73.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.49%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLICHECK INC

NASDAQ:IDN (7/3/2025, 7:36:53 PM)

5.37

+0.2 (+3.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06
Inst Owners41.52%
Inst Owner Change-4.4%
Ins Owners4.54%
Ins Owner Change-0.55%
Market Cap106.54M
Analysts77.5
Price Target5.48 (2.05%)
Short Float %1.6%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)128.88%
Min EPS beat(2)25.75%
Max EPS beat(2)232.01%
EPS beat(4)3
Avg EPS beat(4)25.32%
Min EPS beat(4)-197.1%
Max EPS beat(4)232.01%
EPS beat(8)6
Avg EPS beat(8)180.82%
EPS beat(12)9
Avg EPS beat(12)123.7%
EPS beat(16)10
Avg EPS beat(16)90.53%
Revenue beat(2)2
Avg Revenue beat(2)8.85%
Min Revenue beat(2)1.3%
Max Revenue beat(2)16.39%
Revenue beat(4)2
Avg Revenue beat(4)1.93%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)16.39%
Revenue beat(8)4
Avg Revenue beat(8)1.68%
Revenue beat(12)6
Avg Revenue beat(12)1.22%
Revenue beat(16)9
Avg Revenue beat(16)5.21%
PT rev (1m)65.38%
PT rev (3m)65.38%
EPS NQ rev (1m)-50.04%
EPS NQ rev (3m)-50.04%
EPS NY rev (1m)37.5%
EPS NY rev (3m)37.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)4.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 106.34
P/S 5.27
P/FCF N/A
P/OCF N/A
P/B 6.05
P/tB 15.07
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY0.94%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.02
BVpS0.89
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.23%
ROE -4.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.61%
FCFM N/A
ROA(3y)-9.95%
ROA(5y)-13.83%
ROE(3y)-12.48%
ROE(5y)-17.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y0.85%
F-Score2
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 322.01%
Cap/Sales 8.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z 2.52
F-Score2
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)241.87%
Cap/Depr(5y)271.66%
Cap/Sales(3y)4.79%
Cap/Sales(5y)4.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y66.33%
EPS Next 2Y73.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.53%
Revenue growth 3Y6.86%
Revenue growth 5Y21.16%
Sales Q2Q%4.57%
Revenue Next Year13.28%
Revenue Next 2Y13.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-230.94%
OCF growth 3YN/A
OCF growth 5YN/A